Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patents.

Drug Delivery
Sultan AlshehriFaiyaz Shakeel

Abstract

In the last few decades, solid dispersion (SD) technology had been studied as an approach to produce an amorphous carrier to enhance the solubility, dissolution rate, and bioavailability of poorly water-soluble drugs. The use of suitable carrier and methodology in the preparation of SDs play a significant role in the biological behavior of the SDs. SDs have been prepared using a variety of pharmaceutically acceptable polymers utilizing various novel technologies. In the recent years, much attention has been paid toward the use of novel carriers and methodologies in exploring novel types of SDs to enhance therapeutic efficacy and bioavailability. The use of novel carriers and methodologies would be very beneficial for formulation scientists to develop some SDs-based formulations for their commercial use and clinical applications. In the present review, current literature of novel methodologies for SD preparation to enhance the dissolution rate, solubility, therapeutic efficacy, and bioavailability of poorly water-soluble drugs has been summarized and analyzed. Further, the current status of SDs, patent status, and future prospects have also been discussed.

References

Jan 7, 1999·Drug Development and Industrial Pharmacy·J KercB Kofler
Jan 5, 2002·International Journal of Pharmaceutics·Duncan Q M Craig
Sep 25, 2002·International Journal of Pharmaceutics·Gabriel SertsouThomas Rades
Jun 6, 2003·International Journal of Pharmaceutics·Anette SeoTorben Schaefer
Aug 23, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fude CuiYoshiaki Kawashima
Aug 9, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Dirk-Jan van DroogeHenderik W Frijlink
Sep 6, 2005·International Journal of Pharmaceutics·Thomas VilhelmsenTorben Schaefer
Mar 15, 2006·Drug Discovery Today·Farah Mavandadi, Ake Pilotti
Dec 23, 2006·International Journal of Pharmaceutics·Kirk A OverhoffRobert O Williams
Feb 3, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Evangelos KaravasDimitrios Bikiaris
Sep 25, 2007·Drug Development and Industrial Pharmacy·Michael M CrowleyCharles Martin
Oct 6, 2007·AAPS PharmSciTech·Troy PurvisRobert O Williams
Dec 7, 2007·Drug Discovery Today·Teófilo VasconcelosPaulo Costa
May 27, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Phuong Ha Lien TranBeom-Jin Lee
Jun 25, 2008·International Journal of Pharmaceutics·Mariarosa MoneghiniFrancesco Princivalle
May 23, 2009·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·E VerhoevenC Vervaet
May 26, 2009·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·P SrinarongH W Frijlink
Aug 15, 2009·Journal of Pharmaceutical Sciences·James C DiNunzioJames W McGinity
Mar 11, 2010·International Journal of Pharmaceutics·W AliC F Rawlinson
Aug 18, 2010·International Journal of Pharmaceutics·Deng-Guang YuLi-Min Zhu
Oct 12, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·L SaerensT De Beer
Oct 12, 2010·International Journal of Pharmaceutics·Mohammed M MehannaMagda W Samaha
Jan 6, 2011·Drug Development and Industrial Pharmacy·Nazik ElgindyAhmed Elzoghby
Mar 23, 2011·International Journal of Pharmaceutics·Angéla SzutsPiroska Szabó-Révész
Aug 17, 2011·Advanced Drug Delivery Reviews·Jared A Baird, Lynne S Taylor
Oct 26, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jian X WuJukka Rantanen
May 16, 2012·International Journal of Pharmaceutics·Kohsaku Kawakami
Jul 24, 2012·International Journal of Pharmaceutics·Amrit PaudelGuy Van den Mooter
Sep 11, 2012·AAPS PharmSciTech·Noorullah Naqvi MohammedMichael A Repka
Sep 15, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Meimei ZhangRobert O Williams

❮ Previous
Next ❯

Citations

Jul 22, 2021·Therapeutic Delivery·María Elisa MelianJosé María Bermúdez
Aug 10, 2021·International Journal of Pharmaceutics·Chun-Wan YenDennis H Leung
Aug 23, 2021·International Journal of Pharmaceutics·Nikola PešićDjordje Medarević

❮ Previous
Next ❯

Methods Mentioned

BETA
atomic force microscopy
chip

Software Mentioned

Soluplus

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.